Ricky Hopson, President Clinical Development Supply Division at Catalent, Inc. (CTLT), sold 4,432 shares at $89.59 ($397K) on 2022-08-31, disclosed to the SEC on 2022-09-02.
Open-market sale of $397k CTLT by President Clinical Development Supply Division. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.59 | 2,216 | $199K | 50.0% |
| 2 | $89.59 | 2,216 | $199K | 50.0% |
| Total | $89.59 avg | 4,432 | $397K | 100% |
| Filing → |
| CTLT | SELL | 2024-06-05 | $152K | — | Filing → |
| CTLT | SELL | 2023-08-25 | $12K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $9K | — | Filing → |